Sofosbuvir Plus Daclatasvir With or Without Ribavirin and Chronic HCV Genotype (GT) 4
NCT04387526
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
946
Enrollment
OTHER
Sponsor class
Conditions
Chronic Hepatitis C Virus Infection
Interventions
DRUG:
(SOF and DCV)
DRUG:
(SOF, DCV, and RBV)
Sponsor
Beni-Suef University